Pain Crush

Natural health product licensed in Canada

Licence holder: Genexa Inc.
NPN or DIN-HM: 80103666
Status: Active licence
Licence date: 24 August 2020
Revision date: 22 April 2021
Form: Gel
Route of administration: Topique
Application type: Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source
l-Menthol Source : l-Menthol	7 %

Non-medicinal ingredients

Jus de feuilles d'Aloe Barbadensis, Gomme de xanthane, Glycérine, Ethanol, Eau purifiée, Extrait de racine de Glycyrrhiza Glabra (Réglisse)

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	minimum: 18 years	1 Gel	minimum: 1 Tous les jours ; maximum: 4 Tous les jours

Uses authorised in Canada

Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80103666

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 22 April 2021 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2021. Photograph the packaging to check whether it has changed. Photograph the packaging